Share

EORTC presents at ASH Annual Meeting & Exposition 2017

The EORTC will present 4 abstracts at The American Society of Hematology Annual Meeting (ASH) from December 9 to 12 in Atlanta.

Poster Presentation

  • Long Term Socioeconomic Outcomes of Childhood Acute Lymphoblastic Leukemia (ALL) Survivors Enrolled Between 1971 and 1998 in EORTC Children Leukemia Group Trials 58741, 58831/2 and 58881 (n°2191)

Time: Saturday, December 9, 2017: 5:30 PM-7:30 PM
Location: Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center)
Authors: Melissa Barbati, Michal Kicinski, Stefan Suciu, Yves Benoit, Françoise Mazingue, Els Vandecruys, Geneviève Plat, Anne Uyttebroeck, Patric Lutz, Marie-Françoise Dresse, Pauline Simon, Claire Pluchart, Odile Minckes, Alina Ferster, Claire Freycon, Frederic Millot, Jutte Van Der Werff, Christophe Chantrain, Robert Paulus, Pierre Rohrlich, Teresa De Rojas and Caroline Piette

  • Fertility Status Among Long-Term Childhood Acute Lymphoblastic Leukemia Survivors Enrolled between 1971 and 1998 in the EORTC Children Leukemia Group Trials 58741, 58831/2 and 58881 (n°2563)

Time: Sunday, December 10, 2017: 6:00 PM-8:00 PM
Location: Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center)
Authors: Teresa de Rojas, Michal Kicinski, Stefan Suciu, Yves Benoit, Françoise Mazingue, Els Vandecruys, Geneviève Plat, Anne Uyttebroeck, Patric Lutz, Marie-Françoise Dresse, Pauline Simon, Claire Pluchart, Odile Minckes, Alina Ferster, Claire Freycon, Frederic Millot, Jutte Van Der Werff, Christophe Chantrain, Robert Paulus, Pierre Rohrlich, and Caroline Piette

  • The Impact of Cytogenetic Clonality on Outcomes in Younger Acute Myeloid Leukemia Patients: Results on 1290 Patients Included in the EORTC/Gimema AML-10 and AML-12 Trials (n°1385)

Time: Saturday, December 9, 2017: 5:30 PM-7:30 PM
Location: Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center)
Authors: Frederic Baron, Marian Stevens-Kroef, Michal Kicinski, Giovanna Meloni, Petra Muus, Jean-Pierre Marie, Constantijn J.M. Halkes, Xavier Thomas, Radovan Vrhovac, Crescenza Pasciolla, Francois Lefrere Sr., Simona Sica, Marco Mancini, Adriano Venditti, Anne Hagemeijer, Heiko Becker, Joop H. Jansen, Sergio Amadori, T. M. M de Witte, Roelof Willemze and Stefan Suciu

  • Impact of the Type of Anthracycline and of Allogeneic Stem Cell Transplantation in the Treatment of Younger Acute Myeloid Leukemia Patients: Long-Term Follow-up of the EORTC-Gimema AML-10 Trial (n°3850)

Time: Monday, December 11, 2017: 6:00 PM-8:00 PM
Location: Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center)
Authors: Frederic Baron, Fabio Efficace, Laura Cannella, Franco Mandelli, Petra Muus, Silvia Maria Trisolini, Constantijn J.M. Halkes, Paola Fazi, Marco Vignetti, Jean-Pierre Marie, Patrizia Chiusolo, Walter JFM Van Der Velden, Edoardo La Sala, Umberto Vitolo, Xavier Thomas, Francois Lefrere Sr., Francesco Di Raimondo, Jean-Henri Bourhis, Giorgina Specchia, Jose E. Guimaraes, Bernardino Allione, Radovan Vrhovac, Felicetto Ferrara, Marian Stevens-Kroef, Roelof Willemze, Sergio Amadori, Theo de Witte and Stefan Suciu

Back to news list

Related News

  • EORTC: Advancing research and treatment for rare cancers

  • EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration

  • Appointment of Malte Peters as EORTC Strategic Alliance Officer

  • Unique series of workshops in partnership with the European Medicines Agency (EMA)

  • EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)

  • Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023

  • EORTC Quality of Life measures integrated in CDISC

  • EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma

  • Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia

  • New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023